Indications and uses
helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
do not take more than 6 doses in any 24 hour period this product is not intended for use in children under 12 years of age TSP = teaspoonful adults and children 12 years and over 2 - 4 TSP every 4 hours children under 12 years do not use
each TSP (5 mL) contains: sodium 3 mg store at 20°-25°C (68°-77°F). Do not refrigerate.
Drug Facts
Guaifenesin USP 200 mg
Expectorant
helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
Stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and over | 2 - 4 TSP every 4 hours |
| children under 12 years | do not use |
caramel powder, citric acid, corn syrup, FD&C Red #40, glycerin, menthol, propylene glycol, purified water, saccharin sodium, sodium benzoate
(800) 616-2471
Distributed by
MAJOR
® PHARMACEUTICALS
17177 N Laurel Park Drive, Suite 233,
Livonia, MI 48152
DRUG: ROBAFEN COUGH FORMULA
GENERIC: Guaifenesin
DOSAGE: SYRUP
ADMINSTRATION: ORAL
NDC: 61786-963-45
COLOR: brown
FLAVOR: MENTHOL
PACKAGING: 118 mL in 1 BOTTLE
ACTIVE INGREDIENT(S):
INACTIVE INGREDIENT(S):
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 2 |
| 213155 | Robafen 200 MG in 10 mL Oral Solution | PSN | 2 |
| 213155 | guaifenesin 20 MG/ML Oral Solution [Robafen] | SBD | 2 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 2 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 2 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 2 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 2 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 2 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 2 |
| 213155 | Robafen 100 MG per 5 mL Oral Solution | SY | 2 |
| 213155 | Robafen 200 MG per 10 mL Oral Solution | SY | 2 |
| Class | Version | Type | Effective |
|---|---|---|---|
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61786-963-45 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-1005-f424-e053-dadaa90a57ce | Robafen™ Syrup |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61786-963-45 | ROBAFEN COUGH FORMULA | 118 mL in 1 BOTTLE | SYRUP | 118 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-0061-00 | ML - Milliliter | 0904-0061 | ab74a419-4d6e-4e23-9a99-1f393c107cc2 | 1 | 2013-08-02 |
| 0904-0061-09 | ML - Milliliter | 0904-0061 | 70451862-9fed-4bf4-b236-a2f6f9fab1fd | 1 | 2012-07-24 |
| 0904-0061-16 | ML - Milliliter | 0904-0061 | 5cef9570-dca3-44fb-9657-497b39927422 | 1 | 2013-08-02 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61786-963 | 61786-963-45 |
| 0904-0061 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| MENTHOL, UNSPECIFIED FORM | L7T10EIP3A | IACT |
| CORN SYRUP | 9G5L16BK6N | IACT |
| WATER | 059QF0KO0R | IACT |
| CARAMEL | T9D99G2B1R | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| GUAIFENESIN | 495W7451VQ | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5ad298e3-b90c-5332-e053-2a91aa0a4b4a | f73e1db1-cd54-4e1e-a739-4be0d73ac4a6 | 2017-10-05 | Warnings | 5ad298e3-b90c-5332-e053-2a91aa0a4b4a f73e1db1-cd54-4e1e-a739-4be0d73ac4a6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.